89. Lymphangioleiomyomatosis Clinical trials / Disease details
Clinical trials : 39 / Drugs : 46 - (DrugBank : 20) / Drug target genes : 27 - Drug target pathways : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2007-003745-32-GB (EUCTR) | 12/12/2008 | 26/11/2010 | A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAM | A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAM | Lymphangioleiomyomatosis MedDRA version: 9.1;Level: LLT;Classification code 10049459;Term: Lymphangioleiomyomatosis MedDRA version: 9.1;Level: PT;Term: Lymphangioleiomyomatosis | Trade Name: Doxycycline 100 mg Capsules INN or Proposed INN: doxycycline | University of Nottingham | NULL | Not Recruiting | Female: yes Male: no | United Kingdom |